首页> 美国卫生研究院文献>BMC Cancer >High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition
【2h】

High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition

机译:宫颈癌细胞系C4-II中的高水平可诱导Smad4-表达与预测Smad4在细胞外基质组成中的优先作用的基因表达谱相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSmad4 is a tumour suppressor frequently inactivated in pancreatic and colorectal cancers. We have recently reported loss of Smad4 in every fourth carcinoma of the uterine cervix. Smad4 transmits signals from the TGF-β superfamily of cytokines and functions as a versatile transcriptional co-modulator. The prevailing view suggests that the tumour suppressor function of Smad4 primarily resides in its capability to mediate TGF-β growth inhibitory responses. However, accumulating evidence indicates, that the acquisition of TGF-β resistance and loss of Smad4 may be independent events in the carcinogenic process. Through inducible reexpression of Smad4 in cervical cancer cells we wished to shed more light on this issue and to identify target genes implicated in Smad4 dependent tumor suppression.
机译:BackgroundSmad4是在胰腺癌和结肠直肠癌中经常失活的肿瘤抑制因子。我们最近报道了每四个子宫颈癌中Smad4的丢失。 Smad4传输来自细胞因子TGF-β超家族的信号,并起通用的转录共调节剂的作用。普遍的观点表明,Smad4的肿瘤抑制功能主要在于其介导TGF-β生长抑制反应的能力。然而,越来越多的证据表明,TGF-β耐药性的获得和Smad4的丧失可能是致癌过程中的独立事件。通过在宫颈癌细胞中诱导Smad4的重新表达,我们希望对此问题有更多的了解,并确定与Smad4依赖性肿瘤抑制有关的靶基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号